These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 12586810

  • 1. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival.
    Ferrari S, Briccoli A, Mercuri M, Bertoni F, Picci P, Tienghi A, Del Prever AB, Fagioli F, Comandone A, Bacci G.
    J Clin Oncol; 2003 Feb 15; 21(4):710-5. PubMed ID: 12586810
    [Abstract] [Full Text] [Related]

  • 2. Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience.
    Berlanga P, Cañete A, Salom M, Montalar J, Guasp M, Marco A, Castel V.
    J Pediatr Hematol Oncol; 2016 Apr 15; 38(3):176-81. PubMed ID: 26925713
    [Abstract] [Full Text] [Related]

  • 3. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Hung GY, Yen HJ, Yen CC, Chen WM, Chen PC, Wu HT, Chiou HJ, Chang WH, Hsu HE.
    Ann Surg Oncol; 2015 Apr 15; 22(4):1080-7. PubMed ID: 25323470
    [Abstract] [Full Text] [Related]

  • 4. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
    Tabone MD, Kalifa C, Rodary C, Raquin M, Valteau-Couanet D, Lemerle J.
    J Clin Oncol; 1994 Dec 15; 12(12):2614-20. PubMed ID: 7989936
    [Abstract] [Full Text] [Related]

  • 5. Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children's Research Hospital experience.
    Leary SE, Wozniak AW, Billups CA, Wu J, McPherson V, Neel MD, Rao BN, Daw NC.
    Cancer; 2013 Jul 15; 119(14):2645-53. PubMed ID: 23625626
    [Abstract] [Full Text] [Related]

  • 6. Survival after second and subsequent recurrences in osteosarcoma: a retrospective multicenter analysis.
    Tirtei E, Asaftei SD, Manicone R, Cesari M, Paioli A, Rocca M, Ferrari S, Fagioli F.
    Tumori; 2018 Jun 15; 104(3):202-206. PubMed ID: 30086698
    [Abstract] [Full Text] [Related]

  • 7. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
    Hawkins DS, Arndt CA.
    Cancer; 2003 Dec 01; 98(11):2447-56. PubMed ID: 14635080
    [Abstract] [Full Text] [Related]

  • 8. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases.
    Ward WG, Mikaelian K, Dorey F, Mirra JM, Sassoon A, Holmes EC, Eilber FR, Eckardt JJ.
    J Clin Oncol; 1994 Sep 01; 12(9):1849-58. PubMed ID: 8083708
    [Abstract] [Full Text] [Related]

  • 9. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE, Children's Oncology Group.
    J Clin Oncol; 2008 Feb 01; 26(4):633-8. PubMed ID: 18235123
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
    Ferrari S, Bertoni F, Zanella L, Setola E, Bacchini P, Alberghini M, Versari M, Bacci G.
    Cancer; 2004 May 01; 100(9):1936-42. PubMed ID: 15112275
    [Abstract] [Full Text] [Related]

  • 11. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B, Bielack SS, Jürgens H, Branscheid D, Berdel WE, Exner GU, Göbel U, Helmke K, Jundt G, Kabisch H, Kevric M, Klingebiel T, Kotz R, Maas R, Schwarz R, Semik M, Treuner J, Zoubek A, Winkler K.
    J Clin Oncol; 2005 Jan 20; 23(3):559-68. PubMed ID: 15659502
    [Abstract] [Full Text] [Related]

  • 12. Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
    Bacci G, Briccoli A, Mercuri M, Ferrari S, Bertoni F, Gasbarrini A, Fabbri N, Cesari M, Forni C, Campanacci M.
    J Chemother; 1998 Feb 20; 10(1):69-76. PubMed ID: 9531078
    [Abstract] [Full Text] [Related]

  • 13. Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials.
    Gelderblom H, Jinks RC, Sydes M, Bramwell VH, van Glabbeke M, Grimer RJ, Hogendoorn PC, McTiernan A, Lewis IJ, Nooij MA, Taminiau AH, Whelan J, European Osteosarcoma Intergroup.
    Eur J Cancer; 2011 Apr 20; 47(6):895-902. PubMed ID: 21216138
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
    Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P.
    Cancer; 2006 Mar 01; 106(5):1154-61. PubMed ID: 16421923
    [Abstract] [Full Text] [Related]

  • 15. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, Müller C, Tienghi A, Wiebe T, Comandone A, Böhling T, Del Prever AB, Brosjö O, Bacci G, Saeter G, Italian and Scandinavian Sarcoma Groups.
    J Clin Oncol; 2005 Dec 01; 23(34):8845-52. PubMed ID: 16246977
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.
    Hong S, Shin SJ, Jung M, Jeong J, Lee YJ, Shin KH, Roh JK, Rha SY.
    Oncology; 2011 Dec 01; 80(1-2):107-17. PubMed ID: 21677455
    [Abstract] [Full Text] [Related]

  • 18. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
    Nathan SS, Gorlick R, Bukata S, Chou A, Morris CD, Boland PJ, Huvos AG, Meyers PA, Healey JH.
    Cancer; 2006 Oct 01; 107(7):1607-16. PubMed ID: 16933325
    [Abstract] [Full Text] [Related]

  • 19. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
    Mialou V, Philip T, Kalifa C, Perol D, Gentet JC, Marec-Berard P, Pacquement H, Chastagner P, Defaschelles AS, Hartmann O.
    Cancer; 2005 Sep 01; 104(5):1100-9. PubMed ID: 16015627
    [Abstract] [Full Text] [Related]

  • 20. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N, Carrasco H, Raymond K, Ayala A, Eftekhari F.
    Cancer; 2002 Nov 15; 95(10):2202-10. PubMed ID: 12412175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.